Persistent heterogeneity in diabetes technology reimbursement for children with type 1 diabetes: The SWEET perspective.

Zdenek SumnikAgnieszka SzypowskaVioleta IotovaNatasa BratinaValentino CherubiniGun ForsanderSujata JaliJoao Felipe RaposoGordana StipančicAndriani VazeouHenk VeezeKarin Langenull null

Published in: Pediatric diabetes (2019)

Although innovative diabetes technology is available, a large proportion of children with T1D still do not benefit from it due to its limited reimbursement.

Keyphrases

type diabetes
cardiovascular disease
young adults
glycemic control
adipose tissue
skeletal muscle